Saturn V Capital Management LP 13F Holdings · Q2 2026
Saturn V Capital Management LP reported 23 securities worth $697.47M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: AMLX (11.91%), ALMS (11.76%), ABVX (9.91%). Among its top 25 positions this quarter: 3 new, 13 added, 6 trimmed, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AMLX | AMYLYX PHARMACEUTICALS INC | $83.0M | 11.91% | 4.6M | Added |
| 2 | ALMS | ALUMIS INC | $82.0M | 11.76% | 2.9M | Trimmed |
| 3 | ABVX | ABIVAX SA | $69.1M | 9.91% | 518,865 | Trimmed |
| 4 | PCVX | VAXCYTE INC | $49.6M | 7.11% | 852,914 | Added |
| 5 | IMMX | IMMIX BIOPHARMA INC | $48.0M | 6.89% | 4.7M | Added |
| 6 | PHVS | PHARVARIS N V | $45.4M | 6.52% | 1.3M | Added |
| 7 | JAZZ | JAZZ PHARMACEUTICALS PLC | $38.8M | 5.56% | 160,938 | Trimmed |
| 8 | CELC | CELCUITY INC | $38.7M | 5.55% | 370,318 | Added |
| 9 | IRON | DISC MEDICINE INC | $38.4M | 5.50% | 524,730 | Added |
| 10 | CADL | CANDEL THERAPEUTICS INC | $34.0M | 4.88% | 3.3M | Added |
| 11 | XFOR | X4 PHARMACEUTICALS INC | $32.6M | 4.67% | 7.0M | Added |
| 12 | MNPR | MONOPAR THERAPEUTICS INC | $28.9M | 4.14% | 311,976 | Trimmed |
| 13 | DYN | DYNE THERAPEUTICS INC | $23.5M | 3.37% | 1.1M | Added |
| 14 | TRVI | TREVI THERAPEUTICS INC | $19.6M | 2.81% | 1.1M | New |
| 15 | ZURA | ZURA BIO LTD | $12.4M | 1.78% | 2.1M | Added |
| 16 | SGMT | SAGIMET BIOSCIENCES INC | $11.4M | 1.64% | 1.5M | New |
| 17 | OCS | OCULIS HOLDING AG | $9.5M | 1.36% | 684,880 | Added |
| 18 | IKT | INHIBIKASE THERAPEUTICS INC | $7.9M | 1.13% | 3.9M | Added |
| 19 | VIR | VIR BIOTECHNOLOGY INC | $7.9M | 1.13% | 770,643 | New |
| 20 | IVVD | INVIVYD INC | $7.3M | 1.05% | 8.4M | Trimmed |
| 21 | ANRO | ALTO NEUROSCIENCE INC | $4.8M | 0.69% | 182,829 | Added |
| 22 | MSLE | SATELLOS BIOSCIENCE INC | $2.7M | 0.39% | 350,000 | Hold |
| 23 | OVID | OVID THERAPEUTICS INC | $1.8M | 0.26% | 663,060 | Trimmed |
| 24 | COGT | COGENT BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR